Literature DB >> 11793472

250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.

Dusanka Savić1, Vidosava Rakocvic-Stojanovic, Dusan Keckarevic, Biljana Culjkovic, Oliver Stojkovic, Jelena Mladenovic, Slobodanka Todorovic, Slobodan Apostolski, Stanka Romac.   

Abstract

Myotonic dystrophy type 1 (DM1) is associated with an expansion of CTG repeats in the 3'UTR of the DMPK gene. It is accepted, as in other trinucleotide diseases, that the number of the repeats is correlated with age at onset and severity of the disease. However, assessment of genotype-phenotype correlation in DM1 is complicated with the expansion-biased somatic instability of mutant alleles over time and difficulties in precise assessment of the number of repeats by standard Southern blot hybridization. In order to clarify this issue we defined DM1 expansion size in lymphocytes by three parameters: size of progenitor, average, and largest allele, using a more precise small-pool/long-range PCR technique. We found a negative linear correlation of age at onset and average expansion size in juvenile-adult DM1 patients (35 out of 46) whose progenitor allele is less than 245 repeats long. Our result favors the hypothesis of the existence of a threshold in the progenitor allele size beyond which number of CTG repeats does not influence age at onset. Potential clinical significance is that the average allele size could be a useful indicator for the age at onset in juvenile-adult DM1 patients with relatively short progenitor allele. To test whether somatic instability of mutant alleles influences the progression of DM1, patients were divided in three phenotypic classes according to the severity of neuromuscular symptoms. We showed that the largest expansion in each DM1 phenotypic class reflects somatic instability of mutant allele over time independently of progenitor allele size and patient's age at sampling. The mean of the largest expansion was significantly different between phenotypic classes, implying the possible association between expansion-biased somatic instability of mutant alleles over time and progression of neuromuscular symptoms. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793472     DOI: 10.1002/humu.10027

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.

Authors:  Marka van Blitterswijk; Mariely DeJesus-Hernandez; Ellis Niemantsverdriet; Melissa E Murray; Michael G Heckman; Nancy N Diehl; Patricia H Brown; Matthew C Baker; NiCole A Finch; Peter O Bauer; Geidy Serrano; Thomas G Beach; Keith A Josephs; David S Knopman; Ronald C Petersen; Bradley F Boeve; Neill R Graff-Radford; Kevin B Boylan; Leonard Petrucelli; Dennis W Dickson; Rosa Rademakers
Journal:  Lancet Neurol       Date:  2013-09-05       Impact factor: 44.182

2.  Myotonic dystrophy type I combined with X-linked dominant Charcot-Marie-Tooth neuropathy.

Authors:  Hyun Sook Kim; Ki Wha Chung; Sung Hee Kang; Sung Kyung Choi; Sun Young Cho; Heasoo Koo; Sang-Beom Kim; Byung-Ok Choi
Journal:  Neurogenetics       Date:  2010-05-05       Impact factor: 2.660

3.  Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.

Authors:  Jovan Pešović; S Perić; M Brkušanin; G Brajušković; V Rakočević-Stojanović; Dušanka Savić-Pavićević
Journal:  Neurogenetics       Date:  2017-09-23       Impact factor: 2.660

4.  Analysis of CTG repeat length variation in the DMPK gene in the general population and the molecular diagnosis of myotonic dystrophy type 1 in Malaysia.

Authors:  Kathlin K Ambrose; Taufik Ishak; Lay-Hoong Lian; Khean-Jin Goh; Kum-Thong Wong; Azlina Ahmad-Annuar; Meow-Keong Thong
Journal:  BMJ Open       Date:  2017-03-31       Impact factor: 2.692

5.  The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.

Authors:  Alfonsina Ballester-Lopez; Ian Linares-Pardo; Emma Koehorst; Judit Núñez-Manchón; Guillem Pintos-Morell; Jaume Coll-Cantí; Miriam Almendrote; Giuseppe Lucente; Andrea Arbex; Jonathan J Magaña; Nadia M Murillo-Melo; Alejandro Lucia; Darren G Monckton; Sarah A Cumming; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Gisela Nogales-Gadea
Journal:  Genes (Basel)       Date:  2020-07-07       Impact factor: 4.096

6.  Repeat Interruptions Modify Age at Onset in Myotonic Dystrophy Type 1 by Stabilizing DMPK Expansions in Somatic Cells.

Authors:  Jovan Pešović; Stojan Perić; Miloš Brkušanin; Goran Brajušković; Vidosava Rakočević-Stojanović; Dušanka Savić-Pavićević
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 7.  Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement.

Authors:  Piergiorgio La Rosa; Sara Petrillo; Enrico Silvio Bertini; Fiorella Piemonte
Journal:  Biomolecules       Date:  2020-05-01

Review 8.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

9.  Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.

Authors:  Andrie Koutsoulidou; Tassos C Kyriakides; George K Papadimas; Yiolanda Christou; Evangelia Kararizou; Eleni Zamba Papanicolaou; Leonidas A Phylactou
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.